Rocky Mountain Spotted Fever (RMSF) is a serious and potentially fatal tick-borne bacterial infection caused by Rickettsia rickettsii that affects dogs and humans throughout the Americas. Despite its name suggesting geographic limitation to mountain regions, RMSF occurs throughout much of the United States, with highest incidence in the southeastern and south-central states. This disease represents one of the most severe tick-borne infections affecting dogs, capable of causing rapid clinical deterioration and death within days if not promptly recognized and treated. The gravity of RMSF makes awareness of its presentation and the urgency of treatment essential for owners and veterinarians in endemic areas.
The pathophysiology of RMSF involves bacterial invasion and multiplication within the endothelial cells lining blood vessels throughout the body. Rickettsia rickettsii is an obligate intracellular bacterium, meaning it can only survive and reproduce inside host cells. After transmission through tick bite, the bacteria spread via the bloodstream and lymphatics to infect vascular endothelium in virtually every organ system. This widespread vascular infection produces vasculitis, or inflammation of blood vessels, which underlies all clinical manifestations of the disease. Damaged blood vessels become leaky, leading to edema, hemorrhage, and impaired blood supply to affected tissues and organs.
Clinical presentation of RMSF in dogs typically involves acute onset of severe illness developing two to fourteen days following infected tick attachment. High fever is nearly universal and often exceeds 104°F. Dogs appear profoundly ill with lethargy, depression, and complete loss of appetite. Characteristic features include peripheral edema affecting the limbs, face, and scrotum; petechial hemorrhages visible as tiny red spots on gums and skin; and neurological signs ranging from depression to seizures. The disease progresses rapidly, and dogs can deteriorate from apparently minor illness to life-threatening condition within days. Without treatment, mortality rates in dogs are significant, particularly among certain breeds.
Treatment of RMSF constitutes a medical emergency requiring immediate initiation of appropriate antibiotic therapy. Doxycycline is the treatment of choice and dramatically improves outcomes when started early. Dogs with suspected RMSF should begin treatment immediately based on clinical suspicion without waiting for confirmatory laboratory results, as delays worsen prognosis substantially. Supportive care addresses specific complications including fluid therapy, blood transfusions if needed, and management of organ dysfunction. With prompt, aggressive treatment, most dogs survive and recover fully. Prevention through consistent tick control remains the most effective strategy for avoiding this potentially devastating infection.
